Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 7, Issue 2
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
This article has a correction. Please see:
Correction: Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19 - October 01, 2020
PDF
Editorial
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
Online download statistics by month:
Online download statistics by month: September 2020 to May 2021
Abstract
Full
Pdf
Sep 2020
2278
2260
1064
Oct 2020
1018
994
226
Nov 2020
993
976
157
Dec 2020
3314
3122
655
Jan 2021
2664
2473
466
Feb 2021
847
787
242
Mar 2021
908
829
271
Apr 2021
860
806
259
May 2021
844
802
221
Total
13726
13049
3561
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF